These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 30452049)

  • 1. Engineered fluorescent carbon dots as promising immune adjuvants to efficiently enhance cancer immunotherapy.
    Luo L; Liu C; He T; Zeng L; Xing J; Xia Y; Pan Y; Gong C; Wu A
    Nanoscale; 2018 Nov; 10(46):22035-22043. PubMed ID: 30452049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unprecedented Chiral Nanovaccines for Significantly Enhanced Cancer Immunotherapy.
    Liu H; Xie Z; Zheng M
    ACS Appl Mater Interfaces; 2022 Sep; 14(35):39858-39865. PubMed ID: 36007113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fucoidan can function as an adjuvant in vivo to enhance dendritic cell maturation and function and promote antigen-specific T cell immune responses.
    Jin JO; Zhang W; Du JY; Wong KW; Oda T; Yu Q
    PLoS One; 2014; 9(6):e99396. PubMed ID: 24911024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ascophyllan functions as an adjuvant to promote anti-cancer effect by dendritic cell activation.
    Zhang W; Okimura T; Xu L; Zhang L; Oda T; Kwak M; Yu Q; Jin JO
    Oncotarget; 2016 Apr; 7(15):19284-98. PubMed ID: 27008707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-Penetrating Peptide Enhanced Antigen Presentation for Cancer Immunotherapy.
    Wu H; Zhuang Q; Xu J; Xu L; Zhao Y; Wang C; Yang Z; Shen F; Liu Z; Peng R
    Bioconjug Chem; 2019 Aug; 30(8):2115-2126. PubMed ID: 31339694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineered nano-immunopotentiators efficiently promote cancer immunotherapy for inhibiting and preventing lung metastasis of melanoma.
    Luo L; Iqbal MZ; Liu C; Xing J; Akakuru OU; Fang Q; Li Z; Dai Y; Li A; Guan Y; Wu A
    Biomaterials; 2019 Dec; 223():119464. PubMed ID: 31525691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient antigen gene transduction using Arg-Gly-Asp fiber-mutant adenovirus vectors can potentiate antitumor vaccine efficacy and maturation of murine dendritic cells.
    Okada N; Saito T; Masunaga Y; Tsukada Y; Nakagawa S; Mizuguchi H; Mori K; Okada Y; Fujita T; Hayakawa T; Mayumi T; Yamamoto A
    Cancer Res; 2001 Nov; 61(21):7913-9. PubMed ID: 11691812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting dendritic cells with antigen-containing liposomes: a highly effective procedure for induction of antitumor immunity and for tumor immunotherapy.
    van Broekhoven CL; Parish CR; Demangel C; Britton WJ; Altin JG
    Cancer Res; 2004 Jun; 64(12):4357-65. PubMed ID: 15205352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies.
    Li B; Simmons A; Du T; Lin C; Moskalenko M; Gonzalez-Edick M; VanRoey M; Jooss K
    Clin Immunol; 2009 Nov; 133(2):184-97. PubMed ID: 19664962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.
    Galea-Lauri J; Wells JW; Darling D; Harrison P; Farzaneh F
    Cancer Immunol Immunother; 2004 Nov; 53(11):963-77. PubMed ID: 15146294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined alpha tumor necrosis factor gene therapy and engineered dendritic cell vaccine in combating well-established tumors.
    Liu Y; Saxena A; Zheng C; Carlsen S; Xiang J
    J Gene Med; 2004 Aug; 6(8):857-68. PubMed ID: 15293344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
    da Cunha A; Antoniazi Michelin M; Cândido Murta EF
    Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents.
    Kuhn S; Hyde EJ; Yang J; Rich FJ; Harper JL; Kirman JR; Ronchese F
    J Immunol; 2013 Aug; 191(4):1984-92. PubMed ID: 23858033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uplifting Antitumor Immunotherapy with Lymph-Node-Targeted and Ratio-Controlled Codelivery of Tumor Cell Lysate and Adjuvant.
    Cui G; Sun Y; Qu L; Shen C; Sun Y; Meng F; Zheng Y; Zhong Z
    Adv Healthc Mater; 2024 Jul; 13(17):e2303690. PubMed ID: 38458152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A versatile supramolecular nanoadjuvant that activates NF-κB for cancer immunotherapy.
    Xu Y; Wang Y; Yang Q; Liu Z; Xiao Z; Le Z; Yang Z; Yang C
    Theranostics; 2019; 9(11):3388-3397. PubMed ID: 31244959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen-Loaded Upconversion Nanoparticles for Dendritic Cell Stimulation, Tracking, and Vaccination in Dendritic Cell-Based Immunotherapy.
    Xiang J; Xu L; Gong H; Zhu W; Wang C; Xu J; Feng L; Cheng L; Peng R; Liu Z
    ACS Nano; 2015 Jun; 9(6):6401-11. PubMed ID: 26028363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Enhanced translational efficacy of internal ribosomal entry site-mediated mRNA in dendritic cells contributes to efficient induction of antitumor immunity].
    Tan XH; Wan YH
    Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(6):399-403. PubMed ID: 17456382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liposomes-coated gold nanocages with antigens and adjuvants targeted delivery to dendritic cells for enhancing antitumor immune response.
    Liang R; Xie J; Li J; Wang K; Liu L; Gao Y; Hussain M; Shen G; Zhu J; Tao J
    Biomaterials; 2017 Dec; 149():41-50. PubMed ID: 28992509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-delivery of anionic epitope/CpG vaccine and IDO inhibitor by self-assembled cationic liposomes for combination melanoma immunotherapy.
    Su Q; Wang C; Song H; Zhang C; Liu J; Huang P; Zhang Y; Zhang J; Wang W
    J Mater Chem B; 2021 May; 9(18):3892-3899. PubMed ID: 33928989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imiquimod combined with dendritic cell vaccine decreases Treg proportion and enhances anti-tumor responses in mice bearing melanoma.
    Ren S; Wang Q; Zhang Y; Lu C; Li P; Li Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Feb; 33(2):145-50. PubMed ID: 29762000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.